AbCellera Biologics (ABCL) began trading on the Nasdaq on Fri 11 Dec 20

• Sector(s): Healthcare
• Industry: Biotechnology
• Full Time Employees: 174
• Founded in 2012 
• Headquartered in Vancouver, Canada
• http://www.abcellera.com

AbCellera Biologics  CEO Carl Hansen on CNBC on Wed 1/13/21